Oncology Pharma Inc. (ONPH)

USD 0.0

(100.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2004
Revenue - - - - - 1.18 Million
Cost of Revenue - - 779.00 1109.00 1109.00 654 Thousand
Gross Profit - - -779.00 -1109.00 -1109.00 527 Thousand
Operating Expenses - 62.04 Thousand 14.41 Million 402.77 Thousand 817.75 Thousand 2.22 Million
Selling, General and Administrative Expenses - 62.04 Thousand 14.41 Million 402.77 Thousand 817.75 Thousand 1.85 Million
Research and Development Expenses - - - - - 376 Thousand
Other Expenses - - - - - -
Cost and Expenses - 62.04 Thousand 14.41 Million 403.88 Thousand 818.86 Thousand 2.88 Million
Operating Income - -62.05 Thousand -14.41 Million -403.88 Thousand -818.86 Thousand -1.7 Million
Interest Expense - 104.61 Million 82.8 Million 25 Thousand 31.53 Thousand -
Income Tax Expense - -236.55 Thousand 3494.00 1.00 1.00 -136 Thousand
Earnings before Tax - -104.62 Million -97.46 Million -207.55 Thousand -850.39 Thousand -1.57 Million
Net Income - -104.62 Million -97.47 Million -207.55 Thousand -850.39 Thousand -1.56 Million
Earnings Per Share Basic - -3.42 -6.76 -0.12 -0.72 -782.5 Thousand
Earnings Per Share Diluted - -3.42 -6.76 -0.12 -0.72 -782.5 Thousand
Weighted Average Shares Outstanding 38.56 Million 30.55 Million 14.41 Million 1.68 Million 1.18 Million 2.00
Weighted Average Shares Outstanding (Diluted) 38.56 Million 30.55 Million 14.41 Million 1.68 Million 1.18 Million 2.00
Gross Margin - - - - - 0.45
EBIT Margin - - - - - -1.48
Profit Margin - - - - - -1.33
EBITDA - -7879.00 -14.65 Million -181.44 Thousand -817.75 Thousand -1.75 Million
Earnings Before Tax Margin - - - - - -1.44

Income Statement Charts